ACP
MRSN

Acuta Capital Partners’s Mersana Therapeutics MRSN Stock Holding History

Acuta Capital Partners’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-44,820
Closed -$1.6M – 39
2024
Q4 		$1.6M Sell
44,820
-3,180
-7% -$165K 1.61% 21
2024
Q3 		$2.27M Sell
48,000
-18,520
-28% -$817K 1.84% 19
2024
Q2 		$3.34M Sell
66,520
-20,065
-23% -$1.45M 2.82% 15
2024
Q1 		$9.7M Sell
86,585
-8,135
-9% -$809K 6.3% 3
2023
Q4 		$5.49M Buy
94,720
+90,736
+2,278% +$3.65M 3.09% 14
2023
Q3 		$127K Buy
+3,984
New +$189K 0.09% 44
2023
Q2 		– Sell
-2,400
Closed -$247K – 39
2023
Q1 		$247K Sell
2,400
-35,600
-94% -$5M 0.19% 30
2022
Q4 		$5.57M Buy
+38,000
New +$6.42M 3.43% 13
2021
Q2 		– Sell
-14,308
Closed -$5.79M – 45
2021
Q1 		$5.79M Sell
14,308
-13,452
-48% -$6.52M 2.09% 20
2020
Q4 		$18.5M Buy
27,760
+1,060
+4% +$589K 5.08% 5
2020
Q3 		$12.4M Buy
26,700
+1,400
+6% +$707K 3.65% 8
2020
Q2 		$14.8M Sell
25,300
-7,800
-24% -$2.66M 4.28% 5
2020
Q1 		$4.82M Buy
+33,100
New +$5.78M 2.34% 17

Other funds holding MRSN

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return